Indapamide in the treatment of arterial hypertension

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Diuretics are first-line medicines for the treatment of arterial hypertension. Existing evidentiary data support the fact of morbidity and mortality reduction, benefits of volume and natriuresis control, in particular in reducing the risk of heart failure development due to diuretics intake. At the same time, this group includes rather heterogeneous medicines, among which thiazide-like diuretic indapamide occupies a special place. The optimal balance of efficacy and safety makes it the drug of choice for both monotherapy and combination therapy for various groups of patients with arterial hypertension.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Andrey Syrov

Peoples’ friendship university of Russia

Хат алмасуға жауапты Автор.
Email: syrman2002_1@yahoo.com
ORCID iD: 0000-0002-2536-5781

PhD in Medical Sciences, associate professor of the Department of general medical practice, Medical institute

Ресей, Moscow

Әдебиет тізімі

  1. Clinical guidelines. Arterial hypertension in adults. Russian Society of Cardiology. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2020. ID: 62. URL: https://cr.minzdrav.gov.ru/schema/62_2 (date of access – 01.05.2023) (In Russ.).
  2. Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018; 36(10): 1953–2041. https://dx.doi.org/10.1097/HJH.0000000000001940.
  3. Gabb G., Mangoni A., Arnolda L. Guideline for the diagnosis and management of hypertension in adults – 2016. Med J Aust. 2017; 206(3): 141. https://dx.doi.org/10.5694/mja16.01132.
  4. Leung A., Daskalopoulou S., Dasgupta K. et al. Hypertension Canada’s 2017 Guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017; 33(5): 557–76. https://dx.doi.org/10.1016/j.cjca.2017.03.005.
  5. Task Force of the Latin American Society of Hypertension. Guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2017; 35(8): 1529–45. https://dx.doi.org/10.1097/HJH.0000000000001418.
  6. Whelton P., Carey R., Aronow W. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71(19): e127–e248. https://dx.doi.org/10.1016/j.jacc.2017.11.006.
  7. National Clinical Guideline Centre. Hypertension. The clinical management of primary hypertension in adults (NICE clinical guideline 127). London, United Kingdom. 2011. URL: https://www.nice.org.uk/guidance/ng136/evidence/full-guideline-pdf-6898565198 (date of access – 01.05.2023).
  8. Roush G., Ernst M., Kostis J. et al. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: Antihypertensive and metabolic effects. Hypertension. 2015; 65(5): 1041–46. https://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05021.
  9. Liang W., Ma H., Cao L. et al. Comparison of thiazide-like diuretics versus thiazide-type diuretics: A meta-analysis. J Cell Mol Med. 2017; 21(11): 2634–42. https://dx.doi.org/10.1111/jcmm.13205.
  10. Roush G., Abdelfattah R., Song S. et al. Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2018; 20(10): 1507–15. https://dx.doi.org/10.1111/jch.13386.
  11. Burnier M., Bakris G., Williams B. Redefining diuretics use in hypertension. Why select a thiazide-like diuretic? J Hypertension. 2019; 37(8): 1574–86. https://dx.doi.org/10.1097/HJH.0000000000002088.
  12. Liu L., Wang Z., Gong L. et al. Blood pressure reduction for the secondary prevention of stroke: A Chinese trial and a systematic review of the literature. Hypertension Research. 2009; 32(11): 1032–40. https://dx.doi.org/10.1038/hr.2009.139.
  13. PROGRESS Collaborative group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358(9287): 1033–41. https://dx.doi.org/10.1016/S0140-6736(01)06178-5.
  14. ADVANCE Collaborative Group. ADVANCE – Action in Diabetes and Vascular Disease: Patient recruitment and characteristics of the study population at baseline. Diabet Med. 2005; 22(7): 882–88. https://dx.doi.org/10.1111/j.1464-5491.2005.01596.x.
  15. Beckett N., Peters R., Tuomilehto J. et al. Immediate and late benefits of treating very elderly people with hypertension: Results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ. 2012; 344: d7541. https://dx.doi.org/10.1136/bmj.d7541.
  16. Marre M., Puig J., Kokot F. et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR Study. J Hypertens. 2004; 22(8): 1613–22. https://dx.doi.org/10.1097/01.hjh.0000133733.32125.09.
  17. Zhang Y., Agnoletti D., Wang J. et al. Natriuresis and blood pressure reduction in hypertensive patients with diabetes mellitus: The NESTOR study. J Am Soc Hypertens. 2015; 9(1): 21–28. https://dx.doi.org/10.1016/j.jash.2014.10.003.
  18. Hanon O., Boully C., Caillard L. et al. Treatment of hypertensive patients with diabetes and microalbuminuria with combination indapamide SR/amlodipine: Retrospective analysis of NESTOR. Am J Hypertens. 2015; 28(8) :1064–71. https://dx.doi.org/10.1093/ajh/hpu297.
  19. Holzgreve Н., Risler T., Trenkwalder P. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: The PRIMUS study. Curr Med Res Opin. 2006; 22(9): 1849–58. https://dx.doi.org/10.1185/030079906X132433.
  20. Mourad J.J., Nguyen V., Lopez-Sublet M., Waeber B. Вlood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: Results of the OPTIMAX trial. Vasc Health Risk Manag. 2007; 3(1): 173–80.
  21. Akram J., Sheikh U., Mahmood M., Donnelly R. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: The NATIVE study. Curr Med Res Opin. 2007; 23(12): 2929–36. https://dx.doi.org/10.1185/030079907X242674.
  22. Suchard M., Schuemie M., Krumholz H. et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: A systematic, multinational, large-scale analysis. Lancet. 2019; 394(10211): 1816–26. https://dx.doi.org/10.1016/S0140-6736(19)32317-7.
  23. Chen Y.J., Li L.J., Tang W.L. et al. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Cochrane Database Syst Rev. 2018; 11(11): CD008170. https://dx.doi.org/10.1002/14651858.CD008170.pub3.
  24. Bahtiyar G., Gutterman D., Lebovitz H. Heart failure: A major cardiovascular complication of diabetes mellitus. Curr Diab Rep. 2016; 16(11): 116. https://dx.doi.org/10.1007/s11892-016-0809-4.
  25. de Boer I., Bangalore S., Benetos A. et al. Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care. 2017; 40(9): 1273–284. https://dx.doi.org/10.2337/dci17-0026.
  26. Wang S., Li J., Zhou X. et al. Comparison between the effects of hydrochlorothiazide and indapamide on the kidney in hypertensive patients inadequately controlled with losartan. J Hum Hypertens. 2017; 31(12): 848–54. https://dx.doi.org/10.1038/jhh.2017.51.
  27. Vinereanu D., Dulgheru R., Magda S. et al. The effect of indapamide versus hydrochlorothiazide on ventricular and arterial function in patients with hypertension and diabetes: Results of a randomized trial. Am Heart J. 2014; 168(4): 446–56. https://dx.doi.org/10.1016/j.ahj.2014.06.010.
  28. Senior R., Imbs J.L., Bory M. et al. Indapamide reduces hypertensive left ventricular hypertrophy: An international multicenter study. J Cardiovasc Pharmacol. 1993; 22 (Suppl 6): S106–10.
  29. Liang W., Ma H., Cao L. et al. Comparison of thiazide-like diuretics versus thiazide-type diuretics: A meta-analysis. J Cell Mol Med. 2017; 21(11): 2634–42. https://dx.doi.org/10.1111/jcmm.13205.
  30. Olde Engberink R.H., Frenkel W.J., van den Bogaard B. et al. Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: Systematic review and meta-analysis. Hypertension. 2015; 65(5): 1033–40. https://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05122.
  31. Thomopoulos C., Parati G., Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – overview and meta-analyses. J Hypertens. 2015; 33(2): 195–211. https://dx.doi.org/10.1097/HJH.0000000000000447.
  32. Pedersen S., Gaist D., Schmidt S. et al. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. J Am Acad Dermatol. 2018; 78(4): 673–81e2. https://dx.doi.org/10.1016/j.jaad.2017.11.042.
  33. Pottegard A., Pedersen S., Schmidt S. et al. Association of hydrochlorothiazide use and risk of malignant melanoma. JAMA Intern Med. 2018; 178(8): 1120–22. https://dx.doi.org/10.1001/jamainternmed.2018.1652.
  34. Lu M., Ma L., Wang X. et al. Indapamide suppresses amyloid-β production in cellular models of Alzheimer’s disease through regulating BACE1 activity. Int J Clin Exp Med. 2017; 10(4): 5922–30.
  35. Kaplan N. Indapamide. Is it the better diuretic for hypertension? Hypertension. 2015; 65(5): 983–84. https://dx.doi.org/10.1161/HYPERTENSIONAHA.115.05138.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2023

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>